Fuso Pharmaceutical Industries, Ltd. (4538)
Market Closed
10 Aug, 06:00
JPX JPX Primary 
TWSE ¥
2,191. 00
+26
+1.2009%
¥
18.98B Market Cap
- P/E Ratio
90% Div Yield
21,300 Volume
- Eps
¥ 2,165
Previous Close Want to track 4538 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
4538 closed yesterday higher at ¥2,191, an increase of 1.2009% from Friday's close, completing a monthly increase of 3.4955% or ¥74. Over the past 12 months, 4538 stock lost -5.8444%.
4538 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥45.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Fuso Pharmaceutical Industries, Ltd. has completed 1 stock splits, with the recent split occurring on Sep 28, 2016.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).
Fuso Pharmaceutical Industries, Ltd. (4538) FAQ
What is the stock price today?
The current price is ¥2,191.00.
On which exchange is it traded?
Fuso Pharmaceutical Industries, Ltd. is listed on JPX.
What is its stock symbol?
The ticker symbol is 4538.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 90%.
What is its market cap?
As of today, the market cap is 18.98B.
Has Fuso Pharmaceutical Industries, Ltd. ever had a stock split?
Fuso Pharmaceutical Industries, Ltd. had 1 splits and the recent split was on Sep 28, 2016.
Fuso Pharmaceutical Industries, Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | JPX Exchange | JP3823600006 ISIN |
| Japan Country | 1,370 Employees | 29 Sep 2026 Last Dividend | 28 Sep 2016 Last Split | - IPO Date |
Overview
Fuso Pharmaceutical Industries, Ltd. is a prominent manufacturer and distributor of pharmaceuticals and medical equipment in Japan. Since its incorporation in 1937, Fuso Pharmaceutical has been committed to the development, production, and sales of high-quality healthcare products. Headquartered in Osaka, Japan, the company not only focuses on the Japanese market but also extends its services to contract manufacturing of drugs for other companies, alongside running a real estate leasing business. This diversified approach allows Fuso Pharmaceutical to leverage its expertise in pharmaceuticals while exploring new business avenues.
Products and Services
- Injectables: Fuso Pharmaceutical Industries provides a range of injectable drugs that are used for various medical conditions. These injectables are designed for use in hospitals and clinics, ensuring high-quality standards for patient care.
- Infusions: The company offers infusion solutions that are essential in healthcare for hydrating patients or administering drugs intravenously. These products cater to a broad spectrum of clinical needs, from basic electrolyte replenishment to specialized nutrient mixtures.
- Dialysis Agents for Artificial Kidneys: Specializing in nephrology, Fuso Pharmaceutical manufactures dialysis agents used in artificial kidney machines. These agents help in the dialysis process by cleaning the blood of patients with kidney failure or reduced kidney function.
- Medical Equipment and Devices: Beyond pharmaceuticals, Fuso also develops and sells an array of medical equipment and devices. This diversification into medical technology enables the company to support healthcare providers with tools that enhance patient treatment and care.
- Contract Manufacturing of Drugs: Fuso Pharmaceutical offers contract manufacturing services, utilizing its extensive experience and infrastructure to manufacture drugs on behalf of other pharmaceutical companies. This allows Fuso to leverage its manufacturing capabilities to meet the needs of a global clientele.
- Real Estate Leasing: Expanding its business operations, Fuso Pharmaceutical engages in real estate leasing, including properties that can be utilized for a range of purposes. This segment of their business allows for a steady stream of revenue outside their primary focus on pharmaceuticals and medical devices.
Contact Information
Address: 2-3-11, Morinomiya
Phone: 81 6 6969 1131
Website: https://www.fuso-pharm.co.jp
